Repligen Competitors and Similar CompaniesClear all

Repligen's competitors and similar companies include Purdue Pharma, United Therapeutics, Luminex and Waters.

	Repligen Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.	Purdue Pharma Purdue Pharma is a manufacturer, developer, and marketer of prescription and non-prescription medications.	United Therapeutics United Therapeutics Corporation is a company that develops products for chronic and life-threatening disease treatment.	Luminex Luminex is a company that develops and manufactures multiplexing technologies for researchers and clinicians.	Waters Waters is a company that designs, manufactures, and sells analytical instruments.
Founding Date	Founding Date 1981	Founding Date 1892	Founding Date 1996	Founding Date 1998	Founding Date 1958
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Manufacturing & Industrial biotech drug development life sciences	Tags Healthcare biotech drug development pharma supplements	Tags Healthcare drug development oncology pharma therapy	Tags Manufacturing & Industrial application software biotech drug monitoring life sciences medical diagnostics medtech platform	Tags Manufacturing & Industrial biotech leasing machinery
Locations	Locations Waltham, US HQ Shanghai, CN Jüri, EE Castanet Tolosan, FR Ravensburg, DE Bengaluru, IN Waterford, IE see more	Locations Stamford, US HQ Ewing Township, US Wilson, US	Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US	Locations Austin, US HQ Toronto, CA Shanghai, CN Hong Kong, HK Saluggia, IT Tokyo, JP 's Hertogenbosch, NL see more	Locations Milford, US HQ Rydalmere, AU Wien, AT Antwerpen, BE Sao Paulo, BR Brossard, CA Mississauga, CA see more
Employees	Employees 1,78312% decrease	Employees 925	Employees 1,16819% increase	Employees 1,0546% decrease	Employees 7,9004% decrease
Valuation ($)	Valuation ($) 7.7 b	Valuation ($) N/A	Valuation ($) 15.7 b	Valuation ($) N/A	Valuation ($) 19.3 b
Financial
Revenue (est.)	Revenue (est.) $638.8m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $2.9b (FY, 2024)	Revenue (est.) $417.4m (FY, 2020)	Revenue (est.) $3b (FY, 2024)
Cost of goods	Cost of goods $353.9m (FY, 2023)	Cost of goods N/A	Cost of goods $309.7m (FY, 2024)	Cost of goods $169.5m (FY, 2020)	Cost of goods $1.2b (FY, 2024)
Gross profit	Gross profit $284.8m (FY, 2023)	Gross profit N/A	Gross profit $2.6b (FY, 2024)	Gross profit $247.9m (FY, 2020)	Gross profit $1.8b (FY, 2024)
Net income	Net income $41.6m (FY, 2023)	Net income N/A	Net income $1.2b (FY, 2024)	Net income $15.2m (FY, 2020)	Net income $637.8m (FY, 2024)